Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Microba Life Sciences Limited (AU:MAP)
ASX:MAP
Holding AU:MAP?
Track your performance easily
MAP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.15 - AU$0.23
Previous CloseAU$0.17
Volume21.08K
Average Volume (3M)188.34K
Market Cap
AU$76.13M
Enterprise ValueAU$46.88M
Total Cash (Recent Filing)AU$30.58M
Total Debt (Recent Filing)AU$1.33M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Feb 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares OutstandingN/A
10 Day Avg. Volume266,112
30 Day Avg. Volume188,339
Standard Deviation0.24
R-Squared0.24
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)20.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.39Price Target Upside129.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Microba Life Sciences Limited News
PremiumCompany Announcements
Microba Life Sciences Reports Strong Growth and Expansion
PremiumCompany Announcements
Microba Life Sciences Unveils Q1 FY25 Results
PremiumCompany Announcements
Microba Life Sciences Reports 2024 Financial Results
PremiumCompany Announcements
Microba Life Sciences Announces 2024 AGM and Updates
PremiumCompany Announcements
Microba Divests Research Unit to Focus on Core Business
PremiumCompany Announcements
Microba Life Sciences Showcases Innovations at ASX Conference
PremiumCompany Announcements
Microba Life Sciences Expands Despite Increased LossPremiumCompany Announcements
Microba Life Sciences Governance UpdateMAP FAQ
What was Microba Life Sciences Limited’s price range in the past 12 months?
Microba Life Sciences Limited lowest share price was AU$0.14 and its highest was AU$0.23 in the past 12 months.
What is Microba Life Sciences Limited’s market cap?
Currently, no data Available
When is Microba Life Sciences Limited’s upcoming earnings report date?
Microba Life Sciences Limited’s upcoming earnings report date is Feb 19, 2025 which is in 106 days.
How were Microba Life Sciences Limited’s earnings last quarter?
Microba Life Sciences Limited released its earnings results on Aug 28, 2024. The company reported -AU$0.019 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.019.
Is Microba Life Sciences Limited overvalued?
According to Wall Street analysts Microba Life Sciences Limited’s price is currently Undervalued.
Does Microba Life Sciences Limited pay dividends?
Microba Life Sciences Limited does not currently pay dividends.
What is Microba Life Sciences Limited’s EPS estimate?
Microba Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microba Life Sciences Limited have?
Microba Life Sciences Limited has 447,852,000 shares outstanding.
What happened to Microba Life Sciences Limited’s price movement after its last earnings report?
Microba Life Sciences Limited reported an EPS of -AU$0.019 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.556%.
Which hedge fund is a major shareholder of Microba Life Sciences Limited?
Currently, no hedge funds are holding shares in AU:MAP
---
Microba Life Sciences Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.39 (129.41% Upside)
AU$0.39 (129.41% Upside)
Blogger Sentiment
Bullish
AU:MAP Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.44%
12-Months-Change
Fundamentals
Return on Equity
-49.98%
Trailing 12-Months
Asset Growth
23.61%
Trailing 12-Months
Company Description
Microba Life Sciences Limited
Microba Life Sciences Ltd is a commercial-stage company with leading technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers.
---
MAP Stock 12 Month Forecast
Average Price Target
AU$0.39
▲(129.41% Upside)
Technical Analysis
Race Oncology Ltd.
―
Alcidion Group Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Cyclopharm Limited
―
Best Analysts Covering MAP
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-22.25%
reiterated a buy rating 5 days ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -22.25% per trade.
---